The original antibody was generated by immunizing female BALB/c mice by primary intranasal infection with A2 strain of RSV.

顯示所有 10 筆結果

• 

  查看內容

  Anti-RSV F protein [MEDI-493 (Palivizumab, hu129)] (Ab02241-10.0-BT)

• 

  查看內容

  Anti-RSV F protein [MEDI-493 (Palivizumab, hu129)] (Ab02241-10.0)

• 

  查看內容

  Anti-RSV F protein [MEDI-493 (Palivizumab, hu129)] (Ab02241-10.3-BT)

• 

  查看內容

  Anti-RSV F protein [MEDI-493 (Palivizumab, hu129)] (Ab02241-10.3)

• 

  查看內容

  Anti-RSV F protein [MEDI-493 (Palivizumab, hu129)] (Ab02241-23.0-BT)

• 

  查看內容

  Anti-RSV F protein [MEDI-493 (Palivizumab, hu129)] (Ab02241-23.0)

• 

  查看內容

  Anti-RSV F protein [MEDI-493 (Palivizumab, hu129)] (Ab02241-3.0-BT)

• 

  查看內容

  Anti-RSV F protein [MEDI-493 (Palivizumab, hu129)] (Ab02241-3.0)

• 

  查看內容

  Anti-RSV F protein [MEDI-493 (Palivizumab, hu129)] (Ab02241-3.3-BT)

• 

  查看內容

  Anti-RSV F protein [MEDI-493 (Palivizumab, hu129)] (Ab02241-3.3)